Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Imiquimod vs Aldara in Actinic Keratosis
NCT00948428Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2008
- Primary completion
- Mar 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in actinic keratosis (AK), sponsored by Allergan. Started May 2008; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00948428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948428.